Johnson & Johnson Sponge Cuts Catheter Infection Risk- According to Study

LONDON, March 24 (Reuters) - Johnson & Johnson's antibacterial Biopatch sponge significantly reduced the risk of major infections for critically ill patients in intensive care units, according to a French study published on Tuesday.